19-3281254-T-TCCGG
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_021938.4(CELF5):c.661_664dupCGGC(p.Arg222ProfsTer181) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_021938.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CELF5 | NM_021938.4 | c.661_664dupCGGC | p.Arg222ProfsTer181 | frameshift_variant | Exon 6 of 13 | ENST00000292672.7 | NP_068757.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.661_664dupCGGC variant in the CELF5 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.661_664dupCGGC variant causes a frameshift starting with codon Arginine 222, changes this amino acid to a Proline residue, and creates a premature Stop codon at position 158 of the new reading frame, denoted p.Arg222ProfsX158. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.661_664dupCGGC variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.661_664dupCGGC as a variant of uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at